Flagship explainer
What drives BIOAFFINITY TECHNOLOGIES, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$14.9M | FY2025 |
| |
| Income before tax | −$14.9M | FY2025 |
|
| Operating income | −$10.6M | FY2025 |
|
| $6.2M | FY2025 |
| |
| Ending assets | $11M | FY2025 |
|
| Beginning assets | $6.5M | FY2024 |
|
| $7.3M | FY2025 |
| |
| $2.6M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001493152-26-010143